TSS
AQST icon

Two Sigma Securities’s Aquestive Therapeutics AQST Stock Holding History

Two Sigma Securities’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.9K Buy
+18,770
New +$76.2K 0.01% 1205
2023
Q3 		– Sell
-21,937
Closed -$36.2K – 2905
2023
Q2 		$36.2K Buy
+21,937
New +$39.7K ﹤0.01% 2438

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Securities's AQST Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Aquestive Therapeutics (AQST) in Q1 2026: 18,770 shares worth $77.9K. The stake represents 0.01% of the portfolio and ranks #1205 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in AQST as recently as Q2 2023.

Two Sigma Securities first reported a position in AQST in Q2 2023 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Two Sigma Securities held 18,770 shares of Aquestive Therapeutics worth $77.9K as of Q1 2026.
  • Aquestive Therapeutics was a new Two Sigma Securities position in Q1 2026.
  • Aquestive Therapeutics made up 0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1205 holding.
  • Two Sigma Securities first reported a position in Aquestive Therapeutics in Q2 2023 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.